We just sampled the 2026 Hemi model. Would we have enjoyed our year more if we waited for this iconic engine’s return?

Investing.com - Mizuho has raised its price target on AMD (NASDAQ:AMD) to $275.00 from $205.00 while maintaining an Outperform rating. The semiconductor giant, currently trading at $214.90 with a ...

DA Davidson also maintained a Buy rating on monday.com, keeping a $275 price target after attending the company’s user conference. Cantor Fitzgerald adjusted its price target for monday.com to $257, ...

Whether you want to buy snacks in bulk or save money on discounted electronics, Costco can be a great place to shop. After all, it's well-known for offering a range of household products, such as ...

In an era when cars need much less maintenance, it can be easy to forget the role tires play in a smooth, safe ride. When they’re in good shape, your treads help you avoid skids in the rain or ice, ...

The average household spend on food and drink is on course to rise by £275 this year, prompting shoppers to buy cheaper groceries or prepare simpler meals at home to cut costs. Over the past month, ...

Tesla, Inc. (NASDAQ:TSLA) is one of the AI Stocks on Wall Street’s Radar. On July 17, Barclays reiterated the stock as “Equal Weight with a $275 price target. The firm said it is “confused” ahead of ...

It comes after Opposition Leader Peter Dutton unveiled his National Gas Plan to “ramp up” gas production and establish an east coast gas reserve to bring down prices. Mr Dutton has said the policy ...

Feb 18 (Reuters) - Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who accused the company of conspiring with industry rivals to ...

Evercore ISI analyst Chris McNally raised the firm’s price target on Tesla (TSLA) to $275 from $195 and keeps an In Line rating on the shares. Consistent with the firm’s valuation approach of a “Tale ...

Evercore ISI lowered the firm’s price target on Becton Dickinson (BDX) to $275 from $290 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools ...